Günther Loidl
Chief Tech/Sci/R&D Officer bij BACHEM HOLDING AG
Vermogen: 1 M $ op 31-03-2024
Profiel
Dr. Gnther Loidl is Chief Technology Officer bij Bachem Holding AG. Hij zit in de Raad van Bestuur van Bachem AG. Hij behaalde zijn doctoraat aan het Max Planck Instituut voor Biochemie.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2022 | 14 995 ( 0.02% ) | 1 M $ | 31-03-2024 |
Actieve functies van Günther Loidl
| Bedrijven | Functie | Begin |
|---|---|---|
| BACHEM HOLDING AG | Chief Tech/Sci/R&D Officer | 01-01-2015 |
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Director/Board Member | 01-01-2000 |
Opleiding van Günther Loidl
| Max Planck Institute of Biochemistry | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BACHEM HOLDING AG | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
